Conclusion: The concentration of FGF-23 significantly increased in patients with chronic kidney disease, and is worth predicting changes in factors related to mineral metabolism such as Calcium, Phosphorus, PTH Key words: hronic kidney disease, Fibroblast growth factor 23, Parathyroid hormone, Renal osteodystrophy, Calcium phosphate product